Company Quick10K Filing
Alterola Biotech
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2018-03-31 Quarter: 2018-03-31
10-Q 2017-12-31 Quarter: 2017-12-31
10-K 2017-09-30 Annual: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-K 2016-09-30 Annual: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-Q 2015-12-31 Quarter: 2015-12-31
10-K 2015-09-30 Annual: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-Q 2014-12-31 Quarter: 2014-12-31
10-K 2014-09-30 Annual: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-Q 2013-12-31 Quarter: 2013-12-31
10-K 2013-09-30 Annual: 2013-09-30
10-Q 2013-03-31 Quarter: 2013-03-31
10-Q 2012-12-31 Quarter: 2012-12-31
10-Q 2012-12-31 Quarter: 2012-12-31
10-K 2012-09-30 Annual: 2012-09-30
10-Q 2012-06-30 Quarter: 2012-06-30
10-Q 2012-03-31 Quarter: 2012-03-31
10-Q 2011-12-31 Quarter: 2011-12-31
10-K 2011-09-30 Annual: 2011-09-30
8-K 2019-06-24 Accountant
8-K 2019-05-31 Accountant, Exhibits
8-K 2019-05-27 Enter Agreement, Officers, Exhibits
8-K 2018-03-26 Control, Officers, Exhibits
8-K 2017-06-08 Accountant, Exhibits

Alterola Biotech Financials

-

ALTA Metrics, Comps, Filings


Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Stockholders' Equity

Income Statement ($ Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($ Quarter)

Operating, Investing, Financing

Comps ($ TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Apollo Education (APOL) 1,063,294,900,000 1,955,243,000,000 886,324,000,000 2,000,328,000,000 0 -19,719,000,000 98,213,000,000 579,271,900,000
China Crawfish (CACA) 2,499,000 0 0 0 -4,278,000 -4,278,000 -2,501,000
Mirenco (MREO)
Weyland Tech (WEYL) 10,602,385,000 5,279,803,000 29,462,263,000 -957,570,000 -4,242,435,000 -4,098,835,000 -5,302,921,000
Lingo Media (LMDC) 1,302,004,000 743,410,000 0 0 0 0 -1,000
Granite Real Estate (GRP)
Wewin Group (WWIN) 25,735,000 114,327,000 5,000,000 19,659,000 -95,301,000 -95,301,000 -20,011,000
MWF Global (MWF) 125,000 0 -34,156,000 -34,156,000 -569,000
Frontier Digital Media Group (FDMG) 5,245,000 30,791,000 31,784,000 0 -29,127,000 -29,127,000 -3,427,000
Brighthouse Life Insurance Co of Ny (BHNY) 9,065,749,000,000 8,029,864,000,000 236,819,000,000 0 0 2,514,000,000 -190,199,002,000
G-Mes Holdings (GMES) 1,262,407,000 812,133,000 651,687,000 608,846,000 66,711,000 140,706,000 -30,825,000
Baynon (BNON) 11,303,000 144,518,000 0 0 -20,995,000 -19,951,000 98,696,000
Immune Therapeutics (IMUN) 0 23,672,000 12,552,994,000 0 33,986,000 -5,080,179,000 -5,078,622,000 -21,398,000
Green Planet Bio Engineering (GPLB) 3,000,960,000 0 271,686,000 0 0 -38,208,000 -38,208,000 3,000,959,000
Blue Sphere (BLSP) 894,407,000 43,956,000,000 86,868,000,000 7,950,000,000 2,700,000,000 -14,453,000,000 -14,295,000,000 8,802,407,000
Therapeutic Solutions (TSOI) 0 367,163,000 1,851,159,000 13,260,000 10,130,000 -1,579,387,000 -1,235,683,000 481,264,000
Stem Holdings (STEMH) 40,803,014,000 5,702,703,000 957,741,000 363,932,000 -8,070,014,000 -7,496,304,000 -5,453,599,000
SpringWorks (SWTX)
Clean Coal Technologies (CCTC) 27,229,000 16,748,864,000 0 0 -5,795,085,000 -3,051,616,000 893,654,000
Ryanair Holdings (RYAA) 13,250,700,000,000 8,035,800,000,000 0 0 0 0 -34,900,002,000

Balance Sheet ($)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-31
Cash0000000009,327,0002,493,0002,000,0000013,718,0009,156,0004,849,0002,631,0008,052,0002,818,00000000000
Accounts Receivable
Inventory
PP&E
Assets6,700,0006,200,0006,200,0006,200,0006,200,0006,200,0006,200,0006,200,0006,200,00029,152,00015,037,0008,200,0006,200,0006,200,00019,918,00015,356,00011,049,0008,314,00012,960,0006,951,0003,358,0002,583,0001,808,0001,033,000258,000000
Accounts Payable
Long-Term Debt
Liabilities95,950,000107,876,000110,926,000113,976,000117,026,000121,126,000124,176,000127,226,000130,276,000179,579,000177,220,000188,963,000197,625,000211,542,000233,843,000235,893,000240,393,000249,783,000253,254,000257,879,000261,754,000266,629,000276,605,000281,595,000294,678,000300,553,000306,433,000
Stockholders' Equity-89,250,000-101,676,000-104,726,000-107,776,000-110,826,000-114,926,000-117,976,000-121,026,000-124,076,000-150,427,000-162,183,000-180,763,000-191,425,000-205,342,000-213,925,000-220,537,000-229,344,000-241,469,000-240,294,000-250,928,000-258,396,000-264,046,000-275,572,000-281,337,000-294,678,000-300,553,000-306,433,000
Income Statement ($)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-31
Revenue0000000000000000000000000
Cost of Revenue
Gross Profit
R&D0
SG&A
Tax000000000000000000000000
Net Income-1,000,000-24,384,000
Cash Flow ($)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-31
Cash Operating-11,958,0000000-30,673,000-6,834,000-6,493,000-500,000-2,250,000-6,282,000-4,562,000-4,307,000-2,218,000-19,579,000-5,234,000-2,818,00000000
Cash Investing00000000000
Cash Financing11,958,000000040,000,00006,000,000-1,500,0002,250,00020,000,00000025,000,00000000